Study Title: Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Citation: Molnár et al., 2024 · GeroScience
What the Study Found: This review details how SARS-CoV-2 triggers mitochondrial damage, leading to oxidative stress, inflammation, and impaired energy production that persist in long COVID. It outlines the downstream consequences on multiple organs and highlights (−)-epicatechin and other mitochondrial-targeted compounds as promising therapeutic avenues.
What this means in real life: Long COVID is increasingly understood as a mitochondrial disease at its core — damaged energy factories leave people exhausted and inflamed long after the virus is gone. This review explains the biology and points to compounds like (−)-epicatechin as potential ways to restore mitochondrial function. Mitochondrial support is becoming one of the most logical strategies for helping people recover lasting energy and health after COVID.
Contenu associé
- Can Epicatechin Help Long COVID Fatigue? New Clinical Trial on Inflammation and Cellular Energy → Can Epicatechin Help Long COVID Fatigue? New Clinical Trial on Inflammation and Cellular Energy
- What Happens to Your Mitochondria When You Don’t Sleep Enough? → What Happens to Your Mitochondria When You Don’t Sleep Enough?
- Curious how cellular energy influences recovery and resilience? → Cellular Capacity and Happiness: Where Do Mitochondria Fit In